BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11121380)

  • 1. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle.
    Rocic P; Govindarajan G; Sabri A; Lucchesi PA
    Am J Physiol Cell Physiol; 2001 Jan; 280(1):C90-9. PubMed ID: 11121380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin ii-induced signaling in vascular smooth muscle.
    Rocic P; Lucchesi PA
    J Biol Chem; 2001 Jun; 276(24):21902-6. PubMed ID: 11262415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
    Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells.
    Govindarajan G; Eble DM; Lucchesi PA; Samarel AM
    Circ Res; 2000 Oct; 87(8):710-6. PubMed ID: 11029408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle.
    Sabri A; Govindarajan G; Griffin TM; Byron KL; Samarel AM; Lucchesi PA
    Circ Res; 1998 Oct; 83(8):841-51. PubMed ID: 9776731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation.
    Shah BH; Catt KJ
    Mol Pharmacol; 2002 Feb; 61(2):343-51. PubMed ID: 11809859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
    Eguchi S; Iwasaki H; Inagami T; Numaguchi K; Yamakawa T; Motley ED; Owada KM; Marumo F; Hirata Y
    Hypertension; 1999 Jan; 33(1 Pt 2):201-6. PubMed ID: 9931105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation.
    Sayeski PP; Ali MS
    Exp Cell Res; 2003 Jul; 287(2):339-49. PubMed ID: 12837289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Ca2+-sensitive tyrosine kinase Pyk2 and Src in thrombin signalling in rat astrocytes.
    Wang H; Reiser G
    J Neurochem; 2003 Mar; 84(6):1349-57. PubMed ID: 12614335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
    Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades.
    Blaukat A; Ivankovic-Dikic I; Grönroos E; Dolfi F; Tokiwa G; Vuori K; Dikic I
    J Biol Chem; 1999 May; 274(21):14893-901. PubMed ID: 10329689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H; Zhao ZJ; Landon EJ; Inagami T
    J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells. involvement of geranylgeranylation of small G protein Rap1.
    Satoh K; Ichihara K; Landon EJ; Inagami T; Tang H
    J Biol Chem; 2001 May; 276(19):15761-7. PubMed ID: 11278472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR.
    El Mabrouk M; Touyz RM; Schiffrin EL
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H30-9. PubMed ID: 11406465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth muscle.
    Rocic P; Jo H; Lucchesi PA
    Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1437-44. PubMed ID: 12890645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells.
    Haider UG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM
    Mol Pharmacol; 2002 Oct; 62(4):772-7. PubMed ID: 12237323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle.
    Ginnan R; Singer HA
    Am J Physiol Cell Physiol; 2002 Apr; 282(4):C754-61. PubMed ID: 11880263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.